Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 we » _ we (Expand Search), 5 wt (Expand Search), 5 w (Expand Search)
-
4641
FLIM-FRET measurements with KIRIN1 sensor detects relative changes in intracellular K<sup>+</sup>.
Published 2024“…<b>(Ab)</b> FLIM-FRET measurements of the KIRIN1 sensor expressed in the same cells that were patched in Aa detected decreases in intracellular K<sup>+</sup> in cells expressing CMV:<i>kcnk5b</i>-mCherry (blue) compared to cells lacking the expression of the channel (CMV:mCherry, red). …”
-
4642
Treatment adoption and diffusion pattern.
Published 2023“…The model also projected life expectancy to increase by 15.8%, and incident cases of stroke, pulmonary hypertension, and chronic kidney disease to decrease by 19.8%, 24.5%, and 25.1%, respectively. …”
-
4643
-
4644
-
4645
EC<sub>50</sub> of EP1-4 receptor antagonists on neuroblastoma cell viability <i>in vitro</i>.
Published 2013“…<p>Abbreviations: EC<sub>50</sub>; effective concentration decreasing neuroblastoma cell viability with 50%,</p>a<p>MYCN amplification;</p>b<p>Multidrug-resistant phenotype.…”
-
4646
-
4647
-
4648
Comparison of NK cells and T cell populations based on HIV-1 viremia below and above 50 copies/mL.
Published 2014“…<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0095524#pone-0095524-g003" target="_blank">Figure 3</a> demonstrates that the population percentage of CD3-CD56+CD16+ cells (panel 1) and CD4-CD45RO+CCR7+CD27- cells (panel 2) were decreased in samples with HIV-1 RNA levels of 50–99 copies/mL as compared to samples obtained with HIV-1 RNA below 50 copies/mL with p-values of 0.036 and 0.018, respectively. …”
-
4649
Expression heatmap showing comparison between PAM50 genes subtypes the AR-positive vs AR-negative tumors.
Published 2018“…<p><b>Heat Map using</b> PAM50 gene signature compared to AR status. Genes that are enriched in ER and AR-negative subtypes (blue bar) show complete absence of expression in a subset of the AR-positive subtypes that is traditionally categorized as ‘unclassified’ subtypes (blue arrow). …”
-
4650
-
4651
Image_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.TIF
Published 2021“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
-
4652
Table_1_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX
Published 2021“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
-
4653
Table_2_Samm50 Promotes Hypertrophy by Regulating Pink1-Dependent Mitophagy Signaling in Neonatal Cardiomyocytes.XLSX
Published 2021“…We first found that Samm50 is a key positive regulator of cardiac hypertrophy, for western blot and real-time quantitative PCR detection revealed Samm50 was downregulated both in pressure-overload-induced hypertrophic hearts and Ang II-induced cardiomyocyte hypertrophy. …”
-
4654
-
4655
-
4656
-
4657
-
4658
-
4659
Supplementary Material for: Five-Year Therapy with Recombinant Human Insulin-Like Growth Factor-1 in a Patient with PAPP-A2 Deficiency
Published 2023“…We describe five-year treatment response to recombinant human IGF-1 (rhIGF-1) in a patient with PAPP-A2 deficiency, and the phenotype of PAPP-A2 deficiency in three siblings. …”
-
4660